Maastricht University Medical Center+
Maastricht, Limburg, 6229ER, Netherlands
NCT Number: NCT01034618
The insulinotropic effects of protein hydrolysate/amino acid ingestion have been shown to regulate blood glucose homeostasis in both type 2 diabetes patients and normoglycemic controls. The objective of the study is to investigate the optimal dose of such an insulinotropic mixture.
Looking for future studies?
Notify Me40 year–70 year
Male
Interventional
Not applicable
Maastricht, Limburg, 6229ER, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeMaastricht University Medical Center
Other
The Additional Effects of Protein Hydrolysate Supplementation on Glucose Homeostasis in Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06753994
Behavior, Diabetes
Montreal, Quebec, Canada
View Trial DetailsNCT07843082
Behavior, Body Weight
Oslo, Norway
View Trial DetailsNCT07833384
Arterial Occlusive Diseases, Arteriosclerosis
Baton Rouge, Louisiana, United States
View Trial DetailsNCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial Details